SF
HAE icon

Synovus Financial’s Haemonetics HAE Stock Holding History

Synovus Financial’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,951
Closed -$436K – 841
2021
Q1 		$436K Buy
3,951
+274
+7% +$33.9K ﹤0.01% 585
2020
Q4 		$434K Buy
3,677
+1,028
+39% +$111K 0.01% 574
2020
Q3 		$229K Sell
2,649
-4,614
-64% -$403K ﹤0.01% 653
2020
Q2 		$650K Buy
+7,263
New +$734K 0.01% 405
2015
Q4 		– Sell
-3,300
Closed -$107K – 1020
2015
Q3 		$107K Buy
+3,300
New +$124K ﹤0.01% 493

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

Synovus Financial's HAE Position: Q2 2021 in Review

Synovus Financial sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 3,951 shares — an estimated $436K sold.

Synovus Financial first reported a position in HAE in Q3 2015 and held it in 5 quarters. The position peaked at $650K in Q2 2020. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

  • Synovus Financial reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
  • Synovus Financial sold 3,951 Haemonetics shares in Q2 2021, an estimated $436K.
  • Synovus Financial first reported a position in Haemonetics in Q3 2015 and held it in 5 quarters.
  • Synovus Financial's Haemonetics position peaked at $650K in Q2 2020.
  • 258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on Synovus Financial's 13F filing for Q2 2021, filed 11 Aug 2021.